Prospective randomized study for the comparison of adding adefovir dipivoxil and switching to entecavir in patients with lamivudine-resistant chronic hepatitis B.
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2013
At a glance
- Drugs Adefovir dipivoxil (Primary) ; Entecavir; Lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms ACE
- 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Dec 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 23 Dec 2011 Planned End Date changed from 1 Dec 2010 to 1 Feb 2012 as reported by ClinicalTrials.gov.